A Phase II Trial of Daily Perillyl Alcohol in Patients with Advanced Ovarian Cancer: Eastern Cooperative Oncology Group Study E2E96-Reference-Cited by-同舟云学术

A Phase II Trial of Daily Perillyl Alcohol in Patients with Advanced Ovarian Cancer: Eastern Cooperative Oncology Group Study E2E96

Published:2002-06 Issue:3 Volume:85 Page:464-468
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Bailey Howard H.,Levy Donna,Harris Linda S.,Schink Julian C.,Foss Francine,Beatty Peter,Wadler Scott

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference12 articles.

1. Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study;Creemers;J Clin Oncol,1996

2. Hexamethylmelamine as second-line therapy for platin-resistant ovarian cancer;Vergote;Gynecol Oncol,1992

3. Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study;Thigpen;J Clin Oncol,1994

4. New developments in the treatment of ovarian cancer;Wadler;Exp Opin Investig Drugs,2001

5. The anticancer monoterpene perillyl alcohol causes a decrease in cellular cyclin D1 levels contributing to an early G1 arrest in mammary cells;Shi;Proc Annu Meet Am Assoc Cancer Res,1997

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perillyl Alcohol Promotes Relaxation in Human Umbilical Artery;Current Medicinal Chemistry;2024-12

2. Molecular pharmacology and therapeutic advances of monoterpene perillyl alcohol;Phytomedicine;2024-09

3. Activation of Epstein–Barr Virus’ Lytic Cycle in Nasopharyngeal Carcinoma Cells by NEO212, a Conjugate of Perillyl Alcohol and Temozolomide;Cancers;2024-02-26

4. Incorporation of Perillyl Alcohol into Lipid-Based Nanocarriers Enhances the Antiproliferative Activity in Malignant Glioma Cells;Biomedicines;2023-10-12

5. Enhancing Oral Bioavailability and Brain Biodistribution of Perillyl Alcohol Using Nanostructured Lipid Carriers;Pharmaceuticals;2023-07-25